Daxor Stock (NASDAQ:DXR)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$8.14

52W Range

$7.19 - $10.04

50D Avg

$8.97

200D Avg

$9.04

Market Cap

$39.86M

Avg Vol (3M)

$16.88K

Beta

-0.54

Div Yield

-

DXR Company Profile


Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

37

IPO Date

Jul 25, 1983

Website

DXR Performance


DXR Financial Summary


Dec 23Dec 22Dec 21
Revenue$34.59M$6.31M$5.82M
Operating Income$329.74K$5.25M$4.75M
Net Income$280.64K$5.18M$4.75M
EBITDA$329.74K$5.25M$4.75M
Basic EPS$0.06$0.87$1.17
Diluted EPS$0.06$0.87$1.17

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 23Mar 25, 24 | 8:05 PM
Q4 22Mar 06, 23 | 3:04 PM
Q2 22Aug 26, 22 | 7:06 PM

Peer Comparison


TickerCompany
MHUAMeihua International Medical Technologies Co., Ltd.
KRMDKORU Medical Systems, Inc.
POCIPrecision Optics Corporation, Inc.
LMATLeMaitre Vascular, Inc.
PDEXPro-Dex, Inc.
UTMDUtah Medical Products, Inc.